| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue |
-
|
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
|
-
| | | Operating Expenses | | Research Development | 2,998 | 4,280 | 4,886 | 5,687 | | Selling General and Administrative | 2,007 | 1,096 | 1,744 | 2,058 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 808 | 1,091 | 896 | 935 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (5,812) | (6,467) | (7,527) | (8,680) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (213) | (136) | (108) | 863 | | Earnings Before Interest And Taxes | (6,133) | (6,602) | (7,635) | (7,817) | | Interest Expense | 36 | 48 | 21 | 7 | | Income Before Tax | (6,169) | (6,651) | (7,656) | (7,824) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,169) | (6,651) | (7,656) | (7,824) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (6,169) | (6,651) | (7,656) | (7,824) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($6,169) | ($6,651) | ($7,656) | ($7,824) |
|
0.01% Nasdaq 
0.51%
Income Statement
